SIN therapy downregulated protein expression of Bcl-2 significantly (Figure 1F), increased protein expression of Bax significantly (Figure 1G), and decreased protein expression of PCNA significantly (Figure 2E) in BPH-1 cells. Here, BCL2 is linked to benign prostatic hyperplasia.